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Conspectus
Human α-defensin 6 (HD6) is a 32-residue cysteine-rich peptide that contributes to innate 
immunity by protecting the host at mucosal sites. This peptide is produced in small intestinal 
Paneth cells as an 81-residue precursor peptide that is stored in granules, and is released into the 
lumen. One unusual feature of HD6 is that it lacks the broad-spectrum antimicrobial activity 
observed for other human α-defensins. HD6 exhibits unprecedented self-assembly properties, 
which confer an unusual host-defense function. HD6 monomers self-assemble into higher-order 
oligomers termed “nanonets,” which entrap microbes and prevent invasive pathogens from 
entering host cells. One possible advantage of this host-defense mechanism is that HD6 helps to 
keep microbes in the lumen where they can be killed or removed by other components of the 
immune system, such as recruited neutrophils, or excreted.
In this Account, we report our current understanding of HD6 and focus on work published since 
2012 when Bevins and co-workers first described HD6 nanonets in the literature. First, we present 
studies that address the biosynthesis, storage and maturation of HD6, which demonstrate that 
Nature uses a propeptide strategy to spatially and temporally control the formation of HD6 
nanonets in the small intestine. We subsequently highlight structure-function studies that provide a 
foundation for understanding the molecular basis for why HD6 exhibits unprecedented self-
assembly properties compared to other characterized defensins. Lastly, we consider functional 
studies that illuminate how HD6 contributes to the mucosal immunity. In addition to blocking 
bacterial invasion into host epithelial cells, we recently discovered that HD6 suppresses virulence 
traits displayed by the opportunistic human fungal pathogen Candida albicans. In particular, we 
found that HD6 inhibits C. albicans biofilm formation, which causes complications in the 
treatment of candidiasis. We intend for this Account to inspire further biochemical, biophysical, 
and biological investigations that will advance our understanding of HD6 in mucosal immunity 
and the host-microbe interaction.
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Introduction
Host-defense peptides are abundant components of the innate immune system, which 
provides the first line of defense against microbial pathogens and helps maintain 
homeostatic balance between the host and its resident or commensal microbes.1 These 
peptides are deployed by the host at mucosal surfaces and at sites of infection.2,3 Defensins 
constitute an important class of host-defense peptide that are produced and utilized by lower 
and higher eukaryotes, including humans.4 Since the discovery of defensins several decades 
ago, many investigations have examined structure-function relationships and the roles of 
these peptides in the host-pathogen interaction.5–18
Defensins are small (2–5 kDa) cysteine-rich host-defense peptides expressed by epithelial 
cells and immune cells.4 In mammals, defensins exhibit three conserved and regiospecific 
intramolecular disulfide bonds in the oxidized or disulfide-linked forms (Figure 1). The 
disulfide bonds stabilize a three-stranded β-sheet fold and confer protease resistance.19–22 
The specific disulfide-bond patterns divide the majority of mammalian defensins into two 
subclasses termed α- and β-defensins. The α-defensins exhibit CysI—CysVI, CysII—CysIV, 
CysIII—CysV linkages in the oxidized forms, whereas β-defensins have CysI—CysV, 
CysII—CysIV, CysIII—CysVI disulfide-bond patterns. The numbering scheme indicates the 
relative position of the Cys residues in the primary sequence starting from the N-terminus. 
θ-defensins compose a third subclass of defensins, which were first isolated from rhesus 
monkeys.15,23 Genes encoding θ-defensins are found in humans; however, these genes have 
premature stop codons, which prevent translation of the precursor peptide, and consequently 
humans produce only α- and β-defensins.18
Humans produce six α-defensins named human neutrophil peptides 1–4 (HNP1–4) and 
human enteric defensins 5 and 6 (HD5 and HD6) (Figures 1 and 2).24 HNP1–4 are stored in 
the azurophilic granules of neutrophils,6,7 human monocytes,25 and natural killer cells.26 
HD5 and HD6 are abundant in the granules of Paneth cells,8,27–29 secretory cells located at 
the bases of the crypts of Lieberkühn in the small intestine (Figure 3).30,31 Paneth cells 
package a cocktail of antimicrobial peptides and proteins in granules and release this 
mixture into the lumen to protect the intestinal epithelium from opportunistic and pathogenic 
microbes.31–33 Release of these host-defense factors is also considered to be important for 
intestinal homeostasis.33
Most α-defensins exhibit broad-spectrum antimicrobial activity,3,18,34,35 and early studies 
revealed that defensins disrupt bacterial cell membranes. These observations, at least in part, 
afforded a generalized model whereby membrane destabilization results in bacterial cell 
death.4 In recent years, this model has been questioned to some degree because further 
investigations of select defensins illuminated alterative modes or multiple modes of 
action.36–40 Despite several conserved structural features, including the disulfide bonds and 
tertiary structure, the primary sequences of defensins are variable within a subclass. The 
different amino acid sequences afford variable net charge and hydrophobicity, and such 
diversity at the amino acid level can afford different biophysical and functional properties. 
For α-defensins, a comparison of HD5 and HD6 exemplifies this notion because HD5 
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exhibits broad-spectrum microbiocidal activity whereas HD6, at least in the oxidized form, 
exhibits negligible cell killing ability.19,22,35,38,41
Indeed, the functional role of HD6 was enigmatic for many years because no convincing 
antimicrobial activity could be identified during in vitro studies. In 2012, Bevins and co-
workers reported seminal work using an HD6 transgenic mouse, which demonstrated that 
the peptide provides defense against the Gram-negative gastrointestinal pathogen Salmonella 
enterica serovar Typhimurium (S. Typhimurium) by an unprecedented mechanism.38 Rather 
than killing S. Typhimurium, the researchers found that HD6 oligomerizes into extended 
structures described as “nanonets” that entrap the bacteria in the intestinal lumen and 
thereby prevent bacterial invasion of the host epithelium and subsequent dissemination to 
other organs.38 Evidence for higher-ordered HD6 oligomers was observed in vivo (Figure 4) 
and further supported by in vitro studies. Although this behavior has not been found for 
other characterized defensins, the mechanism of bacterial entrapment is reminiscent of 
neutrophil extracellular traps (NETs), which form when neutrophils release chromatin and 
thereby create an extracellular web-like structure that entangles invading microbes.42
Our laboratory initiated studies of the two human Paneth cell defensins in 2009. A 
significant portion of our research focuses on transition metal homeostasis and the host-
microbe interaction, and our initial interest in HD5 and HD6 originated from our fascination 
with a labile zinc store of unknown function that is contained in Paneth cell granules.43–45 
Although we remain interested in Paneth cell zinc, the report of HD6 nanonets fascinated us 
and motivated us to ask other questions. How do Paneth cell granules package HD6? When 
and how to the nanonets form? What are additional contributions of HD6 to mucosal 
immunity? In this Account, we present recent advances in our understanding of HD6 with 
focus on the biophysical and functional properties of this host-defense peptide. We highlight 
studies that afforded a model for HD6 storage and maturation,46 the molecular basis for 
oligomerization,22,38 and explorations of functional activity at the host/microbe 
interface.22,38,47 We intend for this synopsis to provide an introduction for the broad 
chemical community and newcomers to the field, and inspire future chemical and biological 
investigations of this remarkable self-assembling host defense peptide.
HD6 Storage and Maturation
In collaboration with the Bevins laboratory, we recently elucidated critical steps in the 
maturation pathway of HD6.46 Because we had difficulty imaging that a Paneth cell granule 
packages and releases a micron-sized nanonet upon microbial stimuli, we hypothesized that 
HD6 is stored in the Paneth cell granules as an inactive form, and that oligomerization to 
create nanonets occurs during or following release into the lumen. Defensins are 
biosynthesized as prepropeptides containing a signal sequence for the secretory pathway 
(“pre” region), an N-terminal “pro” domain, and a C-terminal region that corresponds to the 
mature peptide (i.e. 32-aa HD6). Prior mRNA studies indicated that HD6 is translated as a 
100-residue prepropeptide consisting of a 19-residue signaling sequence, a 49-residue pro 
region, and the C-terminal 32-residue mature HD6.27 Moreover, on the basis of the deduced 
amino acid sequence of proHD6, we identified trypsin as a candidate host protease for 
cleavage of proHD6 at the C-terminal end of Arg68 to release mature HD6 (Figure 5). In 
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addition to entering the intestinal lumen following pancreatic release of trypsinogen, trypsin 
is expressed by human Paneth cells, and is reported to be the processing enzyme for HD5 
maturation.48,49
We therefore proposed and tested a model where HD6 is stored as a propeptide (proHD6), 
and the N-terminal proregion prohibits self-assembly until it is cleaved by trypsin.46 Our ex 
vivo analyses of human intestinal tissues and luminal fluid provided several key insights that 
support this model. Only the oxidized form of proHD6 (81-aa) could be detected in samples 
of intestinal tissue, whereas only the mature oxidized peptide (32-aa) could be detected in 
the luminal fluid. Moreover, immunogold labeling transmission electron microscopy studies 
confirmed that HD6 is co-packaged with HD5 and trypsin in the secretory granules of 
Paneth cells. In vitro enzymatic activity assays performed with recombinant proHD6 
established that this peptide is a substrate for trypsin, and trypsin-catalyzed hydrolysis 
releases HD6. Biophysical and functional evaluation of proHD6 revealed that the propeptide 
lacks the functional properties of HD6. In particular, proHD6 neither self-assembles into 
large oligomers nor causes bacterial agglutination nor prevents microbial invasion into 
human epithelial cells. Trypsin cleavage of the propeptide triggers HD6 self-assembly and 
functional activity. For instance, bacterial agglutination only occurs following cleavage of 
proHD6 (Figure 6). In summary, our investigations of HD6 maturation indicate that Paneth 
cells store the peptide as an inactive propeptide in granules. We reason that either during or 
after release into the lumen, proHD6 is cleaved by trypsin to generate HD6, the mature 32-
residue form found in the intestinal lumen, thereby unleashing innate immune function.
Several unanswered questions regarding proHD6 remain. The structure of proHD6 and the 
molecular basis for how the N-terminal pro region inhibits self-assembly warrant further 
investigation. Moreover, the pro regions of defensins exhibit different primary sequences, 
and whether these pro regions contain a molecular code relevant to defensin storage and 
maturation is unclear. Studies of the proteolytic processing and maturation of α-defensins 
demonstrated that the maturation pathways and proteases involved vary from peptide to 
peptide.46,48,50–53 Some defensins are packaged as propeptides whereas others are stored in 
the mature forms, and both of these packaging strategies occur for human α-defensins. HD5 
and HD6 are stored in Paneth cell granules as propeptides,46,48,54 whereas the HNPs are 
stored in neutrophil granules as the mature peptides.5,55,56 Curiously, the HD5 propeptide is 
cationic (pI ≈ 9.5) whereas the HD6 and HNP propeptides are anionic (pI ≈ 4.5 for HD6; pI 
≈ 5.5 for HNPs). These comparisons indicate that the amino acid sequence and net charge of 
the propeptide region are not reliable indicators of whether a particular propeptide will be 
processed before or after being packaged into granules, at least based on current 
observations. Lastly, although we have implicated trypsin as the processing enzyme for 
proHD6, we cannot rule out the possibility that this peptide is a substrate for another as-yet 
unidentified protease. Along these lines, we note that differences in the proteolytic 
processing of HD5 and HD6 appear to occur in vivo. Prior studies reported that several 
different isoforms of HD5 could be detected in human ileal fluid.48 These isoforms 
presumably result from protease-catalyzed hydrolysis at different positions within the pro 
region of proHD5, and all of these species displayed antibacterial activity.48 In contrast, only 
the 32-residue mature form of HD6 was detected in ileal fluid.46 Nature has therefore 
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employed various strategies for defensin maturation even within a particular subclass for 
reasons that remain unknown and hence warrant further exploration.
HD6 Self-Assembly
The model of HD6 contributing to host defense by forming nanonets has motivated two 
investigations of the molecular basis of its self-assembly and ability to entrap microbes.22,38 
A H27W variant of HD6 was first shown to have defective oligomerization properties.38 
This observation afforded a proposal whereby electrostatic interactions between the 
imidazole ring of His27 and the C-terminal carboxyl group of Leu32 mediate HD6 self-
assembly.38 Subsequent studies by our laboratory demonstrated that the H27A variant 
retained the ability to form higher-order oligomers and displayed functional activity, 
although transmission electron microscopy revealed that the H27A fibrils exhibit different 
morphology than the fibrils formed by HD6 (Figure 7).22 Taken together, these observations 
suggest that the attenuated self-assembly observed for the H27W variant is a consequence of 
the bulky tryptophan sidechain, and that His27 is not required for HD6 to form higher-order 
oligomers in aqueous buffer.
A comparison of the primary sequences of HD6 and other human α-defensins (Figure 2) and 
a reported crystal structure of HD619 (Figures 1 and 8) suggested the importance of 
hydrophobic residues for HD6 self-assembly.22 The positioning of hydrophobic residues in 
the HD6 primary sequence occurs largely in the loop between β2 and β 3 at the N- and C-
termini of the peptide, which differs from the placement of hydrophobic residues in HD5 
and the HNPs (Figure 2).22 Whereas most α-defensins crystallographically characterized to 
date have crystallized as dimers, the crystal structure of HD6 revealed that a hydrophobic 
pocket forms between four HD6 monomers, and these tetramers associate in a fibril-like 
chain (Figure 8).19,22 In the hydrophobic pocket, two monomers each contribute Phe2, Phe29 
and Leu32, and the other two monomers each contribute Val22, Met23, and Ile25. Thus, in a 
structure-function study, we evaluated biophysical and function properties of four HD6 
variants where Phe2, Val22, Ile25 and Phe29 were mutated.22 We observed that Phe2 and 
Phe29 are essential for both HD6 self-assembly and biological function. For example, 
mutation of either Phe2 or Phe29 to Ala (F2A and F29A variants, respectively) inhibits the 
self-assembly of HD6, leading to the absence of the elongated features observed by TEM 
(Figure 7). This conclusion was further supported by analytical ultracentrifugation, which 
demonstrated that the F2A and F29A variants predominantly exists as a monomers and 
dimers, respectively, in aqueous buffer at neutral pH.
Our work established that HD6 forms higher-ordered structures in aqueous buffer and in the 
absence of bacteria or other biomolecules. This behavior differs from what was predicted 
from studies of wild-type and mutant S. Typhimurium treated with HD6, which indicated 
that certain cell surface proteins (i.e. flagellin) contribute to formation of HD6 nanonets and 
suggested that a nucleation site is needed.38 We reason that these observations are not 
mutually exclusive, and expect that further biophysical studies of HD6 structure and 
oligomerization (vide infra) will illuminate various factors that influence HD6 
oligomerization.
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HD6 Blocks Bacterial Invasion into Host Cells
HD6 was first shown to entrap two Gram-negative bacterial pathogens of the gastrointestinal 
tract, S. Typhimurium and Yersinia enterocolitica, and thereby block the ability of these 
microbes to invade mammalian cells.38 Subsequently, we reported that HD6 prevents 
epithelial cell invasion by the Gram-positive gastrointestinal pathogen Listeria 
monocytogenes.22 For instance, the presence of HD6 (≥2.5 µM) causes the percentage of 
Listeria invasion to decrease by ≈5-fold (Figure 9).22 Moreover, HD6 variants that cannot 
form large oligomers (e.g. F2A, F29A) are unable to block Listeria invasion, supporting the 
model where self-assembly is essential for microbial entrapment.22 These results suggest 
that the ability of HD6 to prevent bacterial invasion is broad-spectrum with no apparent 
selectivity for Gram-negative or Gram-positive bacteria, and no preference for a given 
bacterial invasion mechanism. Nevertheless, on the basis of additional experimental 
observations, the interactions between HD6 and various microbial strains likely require 
consideration on a case-by-case basis. Microscopic analysis of different bacterial strains 
treated with HD6 revealed strain-dependent nanonet structures and differences in the amount 
of nanonets wrapping around these microbes,46 and evidence for interactions between HD6 
nanonets and certain cell surface proteins of S. Typhimurium was reported.38 Thus, although 
the end result of HD6-mediated microbial entrapment appears general, the details for how 
the process occurs may vary from microbe to microbe and reflect different molecular 
compositions of bacterial surfaces.
HD6 Prevents Fungal Biofilm Formation
Our recent exploratory work investigating the interplay between HD6 and fungi expands the 
scope of HD6 host-defense function to include eukaryotic pathogens.47 We employed the 
opportunistic human pathogen Candida albicans in these studies. C. albicans is a part of the 
normal flora in healthy individuals and is usually confined to the skin and mucosal surfaces 
such as the gastrointestinal tract.57 Nevertheless, this microbe can cause superficial and 
systemic infections in certain individuals, including infants, the elderly, and 
immunocompromised hosts.58,59 C. albicans can invade into the host epithelium and 
subsequently disseminate, which can result in deleterious bloodstream infections.60 
Moreover, this fungi forms biofilms on surfaces, including medical devices such as 
catheters, which causes enhanced resistance to antifungal drugs and limits treatment 
options.61 Based on the ability of HD6 to block bacterial invasion into host cells, we 
questioned whether the peptide also confers host-defense against C. albicans and other fungi 
by a similar mechanism. Moreover, inspired by a recent study reporting that mucins prevent 
biofilm formation by C. albicans,62 we questioned whether HD6 exhibits similar function. 
Our work revealed that HD6 suppresses two virulence traits of C. albicans, namely biofilm 
formation and cell invasion.47 Indeed, visual inspection of C. albicans cultured in the 
absence or presence of the peptide revealed that HD6 disrupts biofilm formation (Figure 
10A). Quantitative analysis of the biofilm (Figure 10B) and the number of planktonic cells 
in the culture supernatants (Figure 10C) indicated that HD6 reduced the amount of biofilm 
formed in a concentration- and time-dependent manner. For example, 20 µM HD6 reduced 
the amount of biofilm by ≈4- and ≈5-fold compared to the untreated control after 24 and 48 
h, respectively. In contrast, cultures treated with the F2A variant displayed the same amount 
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of biofilm as the untreated control, indicating that the self-assembly of HD6 is essential for 
the inhibition of fungal biofilm formation.
Thus, in addition to MUC5AC62 and other mucins,63,64 HD6 provides a new example of a 
microbe-binding biomolecule that suppresses microbial virulence.65 Employing these host-
defense agents may be a general host-defense mechanism for keeping C. albicans and other 
opportunistic pathogens in a harmless, commensal state. In contrast to mucins, our work 
indicated that HD6 does not prevent the morphological transition of C. albicans from 
budding yeast to virulent hyphae. Mechanistic investigations into the interlay between HD6 
and fungi is a topic for future work. Indeed, we hypothesized that HD6 may interact with 
certain fungal membrane proteins, such as adhesins, and thereby prevent these proteins from 
binding to hydrophobic surfaces and initiating biofilm formation.66,67 This putative 
mechanism is reminiscent to the studies reporting HD6 interactions with membrane proteins 
of S. Typhimurium.38
Summary and Perspectives
HD6 is a remarkable defensin peptide that has captured the host-defense peptide 
community’s interest in recent years because of its unprecedented self-assembly properties 
and innate immune function. Our investigations of HD6, presented in this Account, define 
critical steps in its maturation pathway, provide insight into why its self assembly properties 
differ from those of HD5 and other defensins, and support a model whereby the peptide 
contributes to the barrier function of the intestinal mucosa. Despite these recent advances, 
our fundamental understanding of HD6 remains in its infancy and there are many research 
avenues for future consideration.
From a molecular standpoint, structural elucidation of the HD6 self-assemblies observed by 
microscopy and how these structures respond to varying conditions and the presence of other 
biomolecules will afford important biophysical insights into HD6 oligomerization. 
Moreover, whether the nanonets are a thermodynamic sink or dynamic with HD6 monomers 
or small oligomers associating and dissociating from a larger assembly is unknown. Towards 
understanding the HD6-microbe interaction, further investigations of how HD6 associates 
with microbes, including both commensal organisms and human pathogens, and why the 
nanonet structures appear to be dependent on the bacterial strain by scanning electron 
microscopy are warranted.
From the standpoint of HD6 function in the intestine, many unanswered questions remain. 
Following release into the intestinal mucosa, HD6 encounters other host-defense factors 
performing variable functions to provide barrier function and protect the host from 
potentially harmful microbes. Because the vast majority of studies focus on one host-defense 
molecule and because of the difficulties in recapitulating the complex mucosal environment 
in vitro, we are faced with a paucity of information about the interplay between host-defense 
factors. We speculate that entrapment of bacterial pathogens by HD6 in the lumen not only 
prevents bacterial species that invade host cells from reaching this destination and causing 
infection, but also keeps these bacteria in the intestinal lumen to be killed by other host-
defense factors, such as other Paneth cell antimicrobials and recruited neutrophils. Thus, 
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ascertaining whether there are unappreciated synergies between HD6 and other 
biomolecules will fill a knowledge gap and may provide a clearer picture of how the innate 
immune system functions both in the response to microbial pathogens at mucosal sites and 
in intestinal homeostasis. Moreover, consideration of the function and fate of HD6 nanonets 
within pathophysiological contexts such as intestinal inflammation is warranted.
In closing, we are currently faced with a global public health problem of antibiotic resistant 
microbial infections. Fundamental understanding of the different strategies utilized by the 
immune system to counteract microbial challenge provides a foundation for new approaches 
to treating infectious disease. HD6 provides a novel example of how Nature uses self-
assembly for a beneficial outcome. Nanonet formation from a 32-residue cysteine-rich 
peptide to capture pathogens is a remarkable strategy for protecting the host from the harm 
caused by microbial invaders. Along these lines, we reason that mimicking the HD6 host-
defense strategy may provide a non-traditional therapeutic strategy to combat microbial 
infections in humans.
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Figure 1. 
Amino acid sequence of HD6 (top) and crystal structure (bottom) of the monomer. The 
numbers represent amino acid position. The cysteine residues in red compose the Cys4—
Cys31, Cys6—Cys20, and Cys10—Cys30 disulfide linkages (black lines). The salt-bridge 
between Arg7 and Glu14 is indicated as a dashed line. The secondary structure depiction is 
based on the crystal structure shown below (PDB: 1ZMQ19) illustrating the three-stranded 
β-sheet fold of the HD6 monomer. In the monomer structure, the disulfide bonds are shown 
in yellow.
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Figure 2. 
Amino acid sequence alignment of the six human α-defensins. The cysteine residues are 
colored red and the red lines represent the conserved disulfide linkages.
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Figure 3. 
Cartoon depiction of a small intestinal crypt illustrating the location and abundance of 
Paneth cells and the release of enteric α-defensins HD5 and HD6 into the lumen.
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Figure 4. 
Scanning electron micrographs of wild-type (left) and HD6 transgenic (right) mouse ileal 
loop directly inoculated with S. Typhimurium.38 The rod-shaped objects are S. 
Typhimurium. A web-like structure in the HD6 transgenic mouse image, which is not 
observed in the wild-type mouse image, provides in vivo evidence for the formation of HD6 
nanonets. The detailed molecular composition of this web-like structure is unknown. Scale 
bar = 2 µm. Copyright 2012 American Association for the Advancement of Science.
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Figure 5. 
Amino acid sequences of proHD6 and HD6, and proposed maturation pathway. The pro 
region is in green, the sequence of mature HD6 is in purple, and the disulfide linkages are 
depicted as black lines.
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Figure 6. 
TEM analysis of HD6 self-assembly and SEM analysis of bacterial agglutination.46 Top 
row: transmission electron micrographs of 10 mM sodium phosphate pH 7.4 (control), 0.4 
µM trypsin (control), 20 µM proHD6 in the absence and presence of 0.4 µM trypsin, and 20 
µM HD6. All the samples were incubated at room temperature for 1 h. Scale bar = 100 nm. 
Middle row: scanning electron micrographs of E. coli ATCC 25922 treated with 50 mM 
Tris-maleate pH 6.4 (control), 0.4 µM APMSF-inactivated trypsin (control), 3 µM proHD6, 
3 µM trypsin-cleaved proHD6, or 3 µM HD6. Scale bar = 20 µm. Bottom row: SEM of L. 
monocytogenes ATCC19115 treated under the same conditions as in the middle row. Scale 
bar = 20 µm. Copyright 2016 Royal Society of Chemistry.
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Figure 7. 
Transmission electron micrographs of 20 µM HD6 and variants (10 mM sodium phosphate 
buffer, pH 7.4).22 Scale bar = 200 nm. Copyright 2014 American Chemical Society.
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Figure 8. 
Extended crystal structure of HD6 (PDB: 1ZMQ19) and a close-up view of the hydrophobic 
pocket. Hydrophobic residues are shown in orange. Individual HD6 monomers are labeled 
A–D.
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Figure 9. 
Invasion of human T84 epithelial cells by L. monocytogenes ATCC 19115 in the presence of 
HD6 and the F2A variant (mean ± SDM, n = 3).22
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Figure 10. 
HD6 attenuates biofilm formation by C. albicans.47 (A) Macroscopic view of biofilms of C. 
albicans SC5314 grown in the presence of HD6 or the F2A variant. The well diameter is 
15.6 mm. (B) The amount of C. albicans biofilm starting from the yeast state in the presence 
of HD6 or 20 µM F2A. In this assay, greater absorbance at 550 nm indicates greater biofilm 
formation. (C) The CFU/mL of C. albicans in the supernatant after treatment with HD6 or 
F2A, which provides a measure of planktonic cells. The quantification presented in panels C 
and D was performed for the same samples. An asterisk indicates that no colony was 
detected. Copyright 2017 American Chemical Society.
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